Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 306,866 | 86,454 | 58,367 | 7,857 | 29,389 |
| Marketable Securities | 156,806 | 166,155 | 201,763 | 0 | 34,921 |
| Receivables | 10,496 | 4,597 | 5,413 | 0 | N/A |
| Inventories | 8,817 | 85 | N/A | N/A | N/A |
| Other current assets | 13,920 | 9,944 | 1,302 | 1,209 | 218 |
| TOTAL | $496,905 | $267,235 | $266,845 | $9,066 | $64,528 |
| Non-Current Assets | |||||
| PPE Net | 5,261 | 5,696 | 77 | 177 | 10 |
| Intangibles | 83,051 | 88,914 | 1,221 | 1,341 | 1,460 |
| Other Non-Current Assets | 14,033 | 3,416 | 661 | 100 | 69 |
| TOTAL | $102,345 | $98,026 | $1,959 | $1,618 | $1,539 |
| Total Assets | $599,250 | $365,261 | $268,804 | $10,684 | $66,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,216 | 30,969 | 16,746 | 24,831 | 9,437 |
| Accrued Expenses | 26,984 | 23,370 | 11,653 | 3,546 | 1,328 |
| Other current liabilities | 2,633 | 968 | 1,875 | 33 | N/A |
| TOTAL | $41,998 | $80,661 | $88,466 | $28,410 | $10,767 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,165 | 25,354 | 58,192 | 0 | 2 |
| Other Non-Current Liabilities | 14,248 | 4,442 | 0 | 0 | 0 |
| TOTAL | $14,248 | $7,876 | $12,513 | $21 | $33 |
| Total Liabilities | $56,246 | $88,537 | $100,979 | $28,431 | $10,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,074 | 89,433 | 66,631 | N/A | N/A |
| Common Shares | 101 | 89 | 67 | 0 | N/A |
| Retained earnings | -481,270 | -522,042 | -296,221 | -174,662 | -91,445 |
| Other shareholders' equity | 5 | -324 | -451 | 99,979 | 99,925 |
| TOTAL | $543,004 | $276,724 | $167,825 | $-17,747 | $55,267 |
| Total Liabilities And Equity | $599,250 | $365,261 | $268,804 | $10,684 | $66,067 |